Alexander Vladimirovich Shestakov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexander Vladimirovich Shestakov has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Arina Alekseevna Mikhailova
Almazov National Medical Research Centre
4 shared publications - Tat'Yana Vladimirovna Saprina
Siberian State Medical University
4 shared publications - Alyona L. Chernyshova
Institute of Oncology and Neurosurgery, E.N. Meshalkin National Medical Research Center, Ministry of Health of the Russian Federation, 630055 Novosibirsk, Russia
1 shared publication - Anastasia A. Bobrysheva1 shared publication
- Anastasia K. Efimova
P. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Radiological Center
1 shared publication - E. G. Akperov
Siberian State Medical University, Ministry of Health of Russia
1 shared publication
Latest Publications
- Open Access
- 15 October 2022
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 21 (3) , 166-180-180
Pathogen-specific molecular imaging and molecular testing methods in the prognosis of the complicated course of diabetic foot syndrome, the risk of amputation, and patient survival
The aim of this review was to provide extended information on current trends in the diagnosis of complicated diabetic foot syndrome (DFS), the most frequent and severe complication of diabetes mellitus, including hightech medical imaging methods and instrumental and laboratory predictors of the complicated course and risk of amputation in DFS.The article provides an analytical review of modern publications over the past 5 years on diagnosis and therapy. Pilot data on the use of high-tech medical imaging methods, assessment of skin microbiota and ulcers in DFS, molecular testing methods in terms of predicting the amputation risk and survival of patients with DFS, as well as the effectiveness of biosensing systems have been systematized, summarized, and subjected to analytical evaluation.The review provides an expert assessment of the capabilities of pathogen-specific molecular imaging using modern positron emission tomography (PET), single-photon emission computed tomography (SPECT), and highenergy radionuclides in bacterial infection to understand its pathogenesis, minimize diagnostic problems, improve antimicrobial treatment, and address fundamental and applied aspects of DFS. Literature data on the assessment of foot perfusion in diabetic patients with varying degrees of limb ischemia by hybrid technologies (SPECT / CT and PET / CT) and new modalities of magnetic resonance imaging (MRI) are also systematized, which contributes to new understanding of the response to revascularization, surgical shunting, and stimulation of angiogenesis within ischemic tissue, as well as potentially to healing of foot ulcers.The review is aimed at substantiating a multidisciplinary approach in DFS, selection, development, and implementation of innovative strategies for diagnostic modalities to identify diabetic foot pathologies, and choice of an adequate method for treating and monitoring the results of therapy in the context of personalized medicine.
- 15 October 2022
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 21 (3) , 166-180-180
Open AccessPathogen-specific molecular imaging and molecular testing methods in the prognosis of the complicated course of diabetic foot syndrome, the risk of amputation, and patient survival
The aim of this review was to provide extended information on current trends in the diagnosis of complicated diabetic foot syndrome (DFS), the most frequent and severe complication of diabetes mellitus, including hightech medical imaging methods and instrumental and laboratory predictors of the complicated course and risk of amputation in DFS.The article provides an analytical review of modern publications over the past 5 years on diagnosis and therapy. Pilot data on the use of high-tech medical imaging methods, assessment of skin microbiota and ulcers in DFS, molecular testing methods in terms of predicting the amputation risk and survival of patients with DFS, as well as the effectiveness of biosensing systems have been systematized, summarized, and subjected to analytical evaluation.The review provides an expert assessment of the capabilities of pathogen-specific molecular imaging using modern positron emission tomography (PET), single-photon emission computed tomography (SPECT), and highenergy radionuclides in bacterial infection to understand its pathogenesis, minimize diagnostic problems, improve antimicrobial treatment, and address fundamental and applied aspects of DFS. Literature data on the assessment of foot perfusion in diabetic patients with varying degrees of limb ischemia by hybrid technologies (SPECT / CT and PET / CT) and new modalities of magnetic resonance imaging (MRI) are also systematized, which contributes to new understanding of the response to revascularization, surgical shunting, and stimulation of angiogenesis within ischemic tissue, as well as potentially to healing of foot ulcers.The review is aimed at substantiating a multidisciplinary approach in DFS, selection, development, and implementation of innovative strategies for diagnostic modalities to identify diabetic foot pathologies, and choice of an adequate method for treating and monitoring the results of therapy in the context of personalized medicine.
- Open Access
- 30 June 2021
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 76 (2) , 196-209
Complex Analysis of Information Technologies Integration and Adoption into Medical Organizations
Nowadays Information Technologies (IT) are taking more and more stable position in the process of work organization in various companies, and particularly among medical organizations. Present-day scientific society has already begun to research the topic of IT integration particularities into the Health organizations. Current article is focused on this issue. Our team has planned and provided a systematic review to understand which barriers can appear in different medical centers during implementation of the innovative IT into working process. The review has been fulfilled according to the designed protocol based on the actual recommendations of Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. In the course of the workflow we have explored 2050 articles complied with the requirements. As a result, 23 key publications have been chosen and analyzed in detail. After considering the list of issues and barriers associated with the IT Implementation into hospitals and medical centers have been highlighted and described. We have classified them to notional clusters depending on the reasons of their appearance as well. In addition our team has defined the list of practical recommendations following which the result of the IT integration will be improved, but the risk of a negative outcome in the future can be eliminated.
- 30 June 2021
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 76 (2) , 196-209
Open AccessComplex Analysis of Information Technologies Integration and Adoption into Medical Organizations
Nowadays Information Technologies (IT) are taking more and more stable position in the process of work organization in various companies, and particularly among medical organizations. Present-day scientific society has already begun to research the topic of IT integration particularities into the Health organizations. Current article is focused on this issue. Our team has planned and provided a systematic review to understand which barriers can appear in different medical centers during implementation of the innovative IT into working process. The review has been fulfilled according to the designed protocol based on the actual recommendations of Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. In the course of the workflow we have explored 2050 articles complied with the requirements. As a result, 23 key publications have been chosen and analyzed in detail. After considering the list of issues and barriers associated with the IT Implementation into hospitals and medical centers have been highlighted and described. We have classified them to notional clusters depending on the reasons of their appearance as well. In addition our team has defined the list of practical recommendations following which the result of the IT integration will be improved, but the risk of a negative outcome in the future can be eliminated.
- Open Access
- 15 May 2021
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 8 (2) , 8-22
Modern concepts of the molecular pathogenesis of thyroid cancer
Thyroid cancer remains the most common malignancy of the endocrine system worldwide. The indicators of its morbidity and mortality rates have been increasing rapidly over the last decades. Most cases of differentiated thyroid cancer (follicular and papillary histotypes) are clinically manifested by nodular goiter frequently combined with uncertain results of cytological diagnosis (categories III and IV according to the Bethesda (Bethesda System for Reporting Thyroid Cytopathology) classification). All of that makes it difficult to choose a proper tactic for patient treatment. It is known that the development, progression, invasion, and metastasis of cancer cells are regulated by a variety of molecular mechanisms. This review describes several molecular aspects of thyroid nodules oncogenesis, as well as its most promising diagnostic tumor markers. Following molecular pathways are described in particular: gene mutations, protein tumor markers, and epigenetic effects of micro-RNA, histones, as well as DNA methylation. The study of the pathogenesis of this disease has a prognostic value and contributes to the search for effective therapeutic and diagnostic methods and their improvement. That is why we also reviewed modern test panels aimed at preoperative differential diagnosis of thyroid nodules. Summarizing the results of world research on this topic allows us not only to expand the understanding of the fundamental processes of oncogenesis, but also to outline promising areas for future experimental research projects. All of that together will contribute to developing new prognostic, diagnostic and therapeutic technologies, and as a result, will improve the quality of medical care for patients with thyroid cancer.
- 15 May 2021
- Published by Publishing House ABV Press in Advances in molecular oncology
- Vol. 8 (2) , 8-22
Open AccessModern concepts of the molecular pathogenesis of thyroid cancer
Thyroid cancer remains the most common malignancy of the endocrine system worldwide. The indicators of its morbidity and mortality rates have been increasing rapidly over the last decades. Most cases of differentiated thyroid cancer (follicular and papillary histotypes) are clinically manifested by nodular goiter frequently combined with uncertain results of cytological diagnosis (categories III and IV according to the Bethesda (Bethesda System for Reporting Thyroid Cytopathology) classification). All of that makes it difficult to choose a proper tactic for patient treatment. It is known that the development, progression, invasion, and metastasis of cancer cells are regulated by a variety of molecular mechanisms. This review describes several molecular aspects of thyroid nodules oncogenesis, as well as its most promising diagnostic tumor markers. Following molecular pathways are described in particular: gene mutations, protein tumor markers, and epigenetic effects of micro-RNA, histones, as well as DNA methylation. The study of the pathogenesis of this disease has a prognostic value and contributes to the search for effective therapeutic and diagnostic methods and their improvement. That is why we also reviewed modern test panels aimed at preoperative differential diagnosis of thyroid nodules. Summarizing the results of world research on this topic allows us not only to expand the understanding of the fundamental processes of oncogenesis, but also to outline promising areas for future experimental research projects. All of that together will contribute to developing new prognostic, diagnostic and therapeutic technologies, and as a result, will improve the quality of medical care for patients with thyroid cancer.
- 1 January 2021
- Published by Russian Vrach, Publishing House Ltd. in Молекулярная медицина
- Vol. 19 (6) , 3-10
MicroRNA and its’ targets: basics of boiinformatic search
МикроРНК - короткие некодирующие последовательности нуклеотидов, представляют собой ключевой механизм эпигенетической регуляции. Контроль экспрессии генов происходит на посттранскрипционном уровне посредством комплементарного связывания микроРНКс соответствующей ей молекулой мРНК, что приводит к деградации последней и прекращению дальнейшей трансляции. На сегодняшний день появляется все больше данных относительно вовлеченности микроРНК в механизм развития сердечнососудистых, эндокринных, злокачественных и других хронических неинфекционных заболеваний, что позволяет рассматривать микроРНК в качестве перспективной основы создания инновационных диагностических, прогностических и лечебных технологий. Однако, исследования по изучению микроРНК значительно усложняются политаргетными влияниями данных молекул, что подчеркивает необходимость тщательного анализа и прогнозирования эффективных взаимодействий микроРНК:мРНК. С целью преодоления настоящего барьера были созданы бионформационные инструменты, позволяющие с определенной точностью просчитывать потенциальные мишени и эффекты микроРНК, тем самым задавая траекторию движения экспериментальным работам. В настоящем обзоре будут рассмотрены основные принципы молекулярного взаимодействия, лежащие в основе алгоритмов работы инструментов биоинформационного поиска для прогнозирования мишеней и микроРНК:мРНК взаимодействий. Кроме того, будут описаны ключевые параметры и основы их интерпретации для наиболее используемых веб-инструментов: TargetScan и DIANA...
- 1 January 2021
- Published by Russian Vrach, Publishing House Ltd. in Молекулярная медицина
- Vol. 19 (6) , 3-10
MicroRNA and its’ targets: basics of boiinformatic search
МикроРНК - короткие некодирующие последовательности нуклеотидов, представляют собой ключевой механизм эпигенетической регуляции. Контроль экспрессии генов происходит на посттранскрипционном уровне посредством комплементарного связывания микроРНКс соответствующей ей молекулой мРНК, что приводит к деградации последней и прекращению дальнейшей трансляции. На сегодняшний день появляется все больше данных относительно вовлеченности микроРНК в механизм развития сердечнососудистых, эндокринных, злокачественных и других хронических неинфекционных заболеваний, что позволяет рассматривать микроРНК в качестве перспективной основы создания инновационных диагностических, прогностических и лечебных технологий. Однако, исследования по изучению микроРНК значительно усложняются политаргетными влияниями данных молекул, что подчеркивает необходимость тщательного анализа и прогнозирования эффективных взаимодействий микроРНК:мРНК. С целью преодоления настоящего барьера были созданы бионформационные инструменты, позволяющие с определенной точностью просчитывать потенциальные мишени и эффекты микроРНК, тем самым задавая траекторию движения экспериментальным работам. В настоящем обзоре будут рассмотрены основные принципы молекулярного взаимодействия, лежащие в основе алгоритмов работы инструментов биоинформационного поиска для прогнозирования мишеней и микроРНК:мРНК взаимодействий. Кроме того, будут описаны ключевые параметры и основы их интерпретации для наиболее используемых веб-инструментов: TargetScan и DIANA...
- Open Access
- 25 November 2018
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 17 (3) , 12-19
Metformin: new perspectives in chemoprevention and therapy of cancer
According to modern data, metformin is a unique drug, which can act not only as sugar-reducing medicine, but also as an antiproliferative element. More and more new researches about metformin effects in oncologic patients appear during last decades. A lot of researchers suppose that metformin is a new promising medicine for chemopreventive and neoadjuvant cancer therapy. This literature review covers current researches of metformin in context of it»s possible antiproliferative effects.
- 25 November 2018
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 17 (3) , 12-19
Open AccessMetformin: new perspectives in chemoprevention and therapy of cancer
According to modern data, metformin is a unique drug, which can act not only as sugar-reducing medicine, but also as an antiproliferative element. More and more new researches about metformin effects in oncologic patients appear during last decades. A lot of researchers suppose that metformin is a new promising medicine for chemopreventive and neoadjuvant cancer therapy. This literature review covers current researches of metformin in context of it»s possible antiproliferative effects.